蔚蓝生物
(603739)
| 流通市值：26.37亿 | | | 总市值：26.37亿 |
| 流通股本：2.53亿 | | | 总股本：2.53亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 286,784,227.66 | 1,198,902,103.15 | 879,639,817.46 | 543,942,046.84 |
| 营业收入 | 286,784,227.66 | 1,198,902,103.15 | 879,639,817.46 | 543,942,046.84 |
| 二、营业总成本 | 273,764,144.88 | 1,093,894,635.23 | 820,194,683.19 | 515,361,328.74 |
| 营业成本 | 159,293,541.73 | 644,687,499.1 | 489,608,253.44 | 303,608,850.07 |
| 税金及附加 | 3,355,090.96 | 9,881,766.88 | 6,748,076.46 | 4,150,270.69 |
| 销售费用 | 43,757,679.08 | 189,684,616.46 | 144,795,003.6 | 91,894,389.47 |
| 管理费用 | 35,634,701.78 | 124,776,474.34 | 89,560,782.57 | 59,572,556.23 |
| 研发费用 | 26,717,261.31 | 110,681,959.47 | 81,196,580.7 | 51,420,612.97 |
| 财务费用 | 5,005,870.02 | 14,182,318.98 | 8,285,986.42 | 4,714,649.32 |
| 其中:利息费用 | 5,410,325.34 | 15,218,209.81 | 9,287,859.29 | 5,664,965.81 |
| 其中:利息收入 | -493,758.29 | 1,584,187.85 | -901,387.49 | -417,629.29 |
| 加:公允价值变动收益 | 38,146 | 9,220,190.93 | 4,613,619.73 | 4,676,609.42 |
| 加:投资收益 | 4,575,081.09 | 6,416,063.94 | 5,066,287.53 | 2,440,784.63 |
| 资产处置收益 | 520,673.21 | 550.46 | 550.46 | 550.46 |
| 资产减值损失(新) | - | -6,519,140.77 | 28,937.4 | - |
| 信用减值损失(新) | -1,839,691.1 | -13,341,312.05 | -2,677,377.1 | -212,759.19 |
| 其他收益 | 6,323,700.16 | 22,116,785.28 | 14,437,667.65 | 9,041,311.94 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 22,637,992.14 | 122,900,605.71 | 80,914,819.94 | 44,527,215.36 |
| 加:营业外收入 | 21,206.79 | 80,268.24 | 81,180.81 | 57,393.86 |
| 减:营业外支出 | 4,284.55 | 485,719.58 | 134,779.1 | 117,051.73 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 22,654,914.38 | 122,495,154.37 | 80,861,221.65 | 44,467,557.49 |
| 减:所得税费用 | 5,492,396.3 | 19,637,913.94 | 13,693,766.45 | 7,588,130.19 |
| 六、净利润 | 17,162,518.08 | 102,857,240.43 | 67,167,455.2 | 36,879,427.3 |
| 持续经营净利润 | 17,162,518.08 | 102,857,240.43 | 67,167,455.2 | 36,879,427.3 |
| 归属于母公司股东的净利润 | 12,722,943.82 | 80,706,911.48 | 55,323,058.81 | 31,469,626.95 |
| 少数股东损益 | 4,439,574.26 | 22,150,328.95 | 11,844,396.38 | 5,409,800.35 |
| (一)基本每股收益 | 0.05 | 0.32 | 0.22 | 0.12 |
| (二)稀释每股收益 | 0.05 | 0.32 | 0.22 | 0.12 |
| 八、其他综合收益 | -4,237.35 | 573,111.07 | 114,953.92 | 238,324.42 |
| 归属于母公司股东的其他综合收益 | -2,845.8 | 583,781.21 | 89,645.62 | 177,872.42 |
| 九、综合收益总额 | 17,158,280.73 | 103,430,351.5 | 67,282,409.12 | 37,117,751.72 |
| 归属于母公司股东的综合收益总额 | 12,720,098.02 | 81,290,692.69 | 55,412,704.44 | 31,647,499.37 |
| 归属于少数股东的综合收益总额 | 4,438,182.71 | 22,139,658.81 | 11,869,704.68 | 5,470,252.35 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-28 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |